vs

Side-by-side financial comparison of Southland Holdings, Inc. (SLND) and Oncology Institute, Inc. (TOI). Click either name above to swap in a different company.

Oncology Institute, Inc. is the larger business by last-quarter revenue ($142.0M vs $104.0M, roughly 1.4× Southland Holdings, Inc.). Oncology Institute, Inc. runs the higher net margin — -5.3% vs -208.2%, a 202.9% gap on every dollar of revenue. On growth, Oncology Institute, Inc. posted the faster year-over-year revenue change (41.6% vs -61.1%). Southland Holdings, Inc. produced more free cash flow last quarter ($9.3M vs $2.2M). Over the past eight quarters, Oncology Institute, Inc.'s revenue compounded faster (22.5% CAGR vs -39.9%).

Southland Holdings, Inc. is a leading North American infrastructure construction firm. It offers full-suite services for transportation projects including highways, bridges and airports, water and wastewater system construction, and commercial site development, serving both public sector and private industry clients across regional core markets.

Oncology Institute, Inc. is a specialized healthcare enterprise focused on delivering patient-centric, evidence-based oncology care services, including advanced treatment regimens, clinical trial access, and supportive care programs. It primarily operates across the United States, serving patients with diverse cancer diagnoses and partnering with care teams to improve treatment outcomes.

SLND vs TOI — Head-to-Head

Bigger by revenue
TOI
TOI
1.4× larger
TOI
$142.0M
$104.0M
SLND
Growing faster (revenue YoY)
TOI
TOI
+102.7% gap
TOI
41.6%
-61.1%
SLND
Higher net margin
TOI
TOI
202.9% more per $
TOI
-5.3%
-208.2%
SLND
More free cash flow
SLND
SLND
$7.1M more FCF
SLND
$9.3M
$2.2M
TOI
Faster 2-yr revenue CAGR
TOI
TOI
Annualised
TOI
22.5%
-39.9%
SLND

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
SLND
SLND
TOI
TOI
Revenue
$104.0M
$142.0M
Net Profit
$-216.4M
$-7.5M
Gross Margin
-186.0%
Operating Margin
-202.4%
-4.9%
Net Margin
-208.2%
-5.3%
Revenue YoY
-61.1%
41.6%
Net Profit YoY
-5108.5%
43.0%
EPS (diluted)
$-4.01
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
SLND
SLND
TOI
TOI
Q4 25
$104.0M
$142.0M
Q3 25
$213.3M
$136.6M
Q2 25
$215.4M
$119.8M
Q1 25
$239.5M
$104.4M
Q4 24
$267.3M
$100.3M
Q3 24
$173.3M
$99.9M
Q2 24
$251.5M
$98.6M
Q1 24
$288.1M
$94.7M
Net Profit
SLND
SLND
TOI
TOI
Q4 25
$-216.4M
$-7.5M
Q3 25
$-75.3M
$-16.5M
Q2 25
$-10.3M
$-17.0M
Q1 25
$-4.6M
$-19.6M
Q4 24
$-4.2M
$-13.2M
Q3 24
$-54.7M
$-16.1M
Q2 24
$-46.1M
$-15.5M
Q1 24
$-406.0K
$-19.9M
Gross Margin
SLND
SLND
TOI
TOI
Q4 25
-186.0%
Q3 25
1.5%
Q2 25
6.2%
Q1 25
9.0%
Q4 24
2.9%
Q3 24
-29.5%
Q2 24
-15.9%
Q1 24
7.1%
Operating Margin
SLND
SLND
TOI
TOI
Q4 25
-202.4%
-4.9%
Q3 25
-5.3%
-5.9%
Q2 25
-0.1%
-9.4%
Q1 25
2.1%
-9.5%
Q4 24
-3.0%
-11.9%
Q3 24
-39.6%
-13.9%
Q2 24
-22.1%
-16.6%
Q1 24
2.1%
-19.0%
Net Margin
SLND
SLND
TOI
TOI
Q4 25
-208.2%
-5.3%
Q3 25
-35.3%
-12.1%
Q2 25
-4.8%
-14.2%
Q1 25
-1.9%
-18.8%
Q4 24
-1.6%
-13.1%
Q3 24
-31.6%
-16.1%
Q2 24
-18.3%
-15.7%
Q1 24
-0.1%
-21.0%
EPS (diluted)
SLND
SLND
TOI
TOI
Q4 25
$-4.01
$-0.04
Q3 25
$-1.39
$-0.14
Q2 25
$-0.19
$-0.15
Q1 25
$-0.08
$-0.21
Q4 24
$-0.08
$-0.14
Q3 24
$-1.14
$-0.18
Q2 24
$-0.96
$-0.17
Q1 24
$-0.01
$-0.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
SLND
SLND
TOI
TOI
Cash + ST InvestmentsLiquidity on hand
$52.7M
Total DebtLower is stronger
$257.7M
Stockholders' EquityBook value
$-140.9M
$-15.7M
Total Assets
$989.3M
$164.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
SLND
SLND
TOI
TOI
Q4 25
$52.7M
Q3 25
$40.5M
Q2 25
$46.5M
Q1 25
$65.1M
Q4 24
$72.2M
Q3 24
$91.4M
Q2 24
$52.4M
$9.9M
Q1 24
$31.2M
$29.8M
Total Debt
SLND
SLND
TOI
TOI
Q4 25
$257.7M
Q3 25
$267.8M
Q2 25
$278.6M
Q1 25
$288.1M
Q4 24
$300.1M
Q3 24
$318.3M
Q2 24
$307.8M
Q1 24
$302.0M
Stockholders' Equity
SLND
SLND
TOI
TOI
Q4 25
$-140.9M
$-15.7M
Q3 25
$75.0M
$-12.3M
Q2 25
$151.1M
$-9.0M
Q1 25
$159.1M
$5.1M
Q4 24
$163.7M
$3.6M
Q3 24
$149.1M
$15.5M
Q2 24
$203.3M
$29.2M
Q1 24
$249.3M
$41.3M
Total Assets
SLND
SLND
TOI
TOI
Q4 25
$989.3M
$164.7M
Q3 25
$1.1B
$163.6M
Q2 25
$1.2B
$159.8M
Q1 25
$1.2B
$164.0M
Q4 24
$1.2B
$172.7M
Q3 24
$1.2B
$179.2M
Q2 24
$1.3B
$179.6M
Q1 24
$1.2B
$204.5M
Debt / Equity
SLND
SLND
TOI
TOI
Q4 25
Q3 25
3.57×
Q2 25
1.84×
Q1 25
1.81×
Q4 24
1.83×
Q3 24
2.14×
Q2 24
1.51×
Q1 24
1.21×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
SLND
SLND
TOI
TOI
Operating Cash FlowLast quarter
$9.7M
$3.2M
Free Cash FlowOCF − Capex
$9.3M
$2.2M
FCF MarginFCF / Revenue
8.9%
1.5%
Capex IntensityCapex / Revenue
0.4%
0.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$12.7M
$-27.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
SLND
SLND
TOI
TOI
Q4 25
$9.7M
$3.2M
Q3 25
$5.9M
$-12.6M
Q2 25
$-5.4M
$-10.2M
Q1 25
$6.4M
$-5.0M
Q4 24
$-10.3M
$4.2M
Q3 24
$-5.3M
$819.0K
Q2 24
$27.4M
$-15.7M
Q1 24
$-9.9M
$-15.9M
Free Cash Flow
SLND
SLND
TOI
TOI
Q4 25
$9.3M
$2.2M
Q3 25
$5.3M
$-13.2M
Q2 25
$-6.5M
$-11.4M
Q1 25
$4.6M
$-5.3M
Q4 24
$-11.5M
$2.4M
Q3 24
$-7.3M
$417.0K
Q2 24
$26.3M
$-17.5M
Q1 24
$-13.0M
$-16.5M
FCF Margin
SLND
SLND
TOI
TOI
Q4 25
8.9%
1.5%
Q3 25
2.5%
-9.7%
Q2 25
-3.0%
-9.5%
Q1 25
1.9%
-5.1%
Q4 24
-4.3%
2.4%
Q3 24
-4.2%
0.4%
Q2 24
10.5%
-17.7%
Q1 24
-4.5%
-17.4%
Capex Intensity
SLND
SLND
TOI
TOI
Q4 25
0.4%
0.7%
Q3 25
0.3%
0.4%
Q2 25
0.5%
1.0%
Q1 25
0.7%
0.3%
Q4 24
0.5%
1.8%
Q3 24
1.1%
0.4%
Q2 24
0.4%
1.9%
Q1 24
1.1%
0.6%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

SLND
SLND

Civil$58.4M56%
Transportation$45.6M44%

TOI
TOI

Other$82.1M58%
Fee For Service$36.3M26%
Capitated Revenue$23.6M17%

Related Comparisons